This press release summarizes New Jersey's civil enforcement recoveries in 2025, totaling $193 million across various settlements including False Claims Act, consumer fraud, and environmental cases. No specific privacy enforcement action is detailed.
The state recovered $193 million in settlements and judgments across various cases.
This press release does not detail a specific privacy enforcement action. In-house legal teams should review their contracts for compliance with New Jersey consumer protection and false claims laws, ensuring that any representations made to consumers are accurate and that environmental and labor practices comply with state regulations.
Entity
Multiple entities
Industry
OtherOfficial Press Release
https://www.njoag.gov/ag-davenport-2025-state-recoveries-reach-193-million/
arkema jco submission to court 20250630
https://dep.nj.gov/wp-content/uploads/arkema/arkema-jco-submission-to-court-20250630.pdf
2026 0624 NWW ACO signed 1 21 25
http://www.njoag.gov/wp-content/uploads/2026/06/2026-0624_NWW-ACO-signed-1-21-25.pdf
2026 0624 Final Order on Default ADS Reno Entered by Court
http://www.njoag.gov/wp-content/uploads/2026/06/2026-0624_Final-Order-on-Default-ADS-Reno-Entered-by-Court.pdf
2026 0624 Taxation POC
http://www.njoag.gov/wp-content/uploads/2026/06/2026-0624_Taxation-POC.pdf
New Jersey Attorney General Enforcement Page
https://www.njoag.gov/about/divisions-and-offices/division-of-consumer-affairs/
"Civil enforcement efforts recouped $193 million for the State of New Jersey in 2025"
"Horizon Healthcare Services"
"False Claims Act"
"Settlements in 2025 included—among other things—the State’s largest-ever non-Medicaid False Claims Act settlement."
$220.0M
A 36-attorney-general coalition resolved allegations that General Motors collected and sold identifiable driver behavior and location data to data brokers, which supplied it to insurers for use in assessing drivers and potentially raising premiums. The $220 million nationwide settlement requires affirmative express consent before collecting or disclosing driving and location data, limits data collection, and imposes privacy-program assessments and dealership oversight and training.
New Jersey, the FTC, and a coalition of 19 other states sued Dollar General, alleging that customers were repeatedly charged more at checkout than prices displayed on shelves, tags, and advertisements. The complaint alleges deceptive pricing practices and inadequate safeguards despite consumer complaints; the release does not describe a settlement, penalty, or other remedy imposed.
New Jersey joined a coalition of state attorneys general in filing a notice in Character Technologies, Inc.’s bankruptcy proceedings, raising concerns about the company’s safety and privacy practices and the sensitive conversations it holds, including those involving children and mental health. The states seek safeguards for consumers’ personal information in any sale or transfer of the company’s business or assets; the release does not report a fine or final finding of violations.
A multistate coalition co-led by New Jersey won a federal court order rejecting the Trump Administration’s decision not to request funding for the CFPB. The order struck down that decision and directed the Administration to follow the law and fund the agency; no monetary penalty or privacy violation is described.
New Jersey’s Attorney General and Division of Consumer Affairs alerted the public that three synthetic kratom-related compounds became illegal to possess or sell in the state under a temporary federal scheduling order. The release describes a controlled-substance alert, not a privacy enforcement action, and identifies no company, privacy violation, or monetary penalty.
$2.3M
Laboratory Corporation of America Holdings agreed to pay $2,287,455 to participating states and strengthen its security and vendor-management practices following an investigation into the 2019 breach at its debt-collection vendor, AMCA. The breach potentially exposed information of more than 27.5 million people nationwide, including sensitive information belonging to approximately 10.2 million LabCorp patients.